Skip to main content
. 2011 Mar 2;6(3):e17030. doi: 10.1371/journal.pone.0017030

Table 4. Impact of ILI on health related quality of life for H1N1v confirmed and non-H1N1v ILI control patients.

Confirmed H1N1v ILI cases ILI controls (non-H1N1v cases)
EQ-5D Background (min-max,median) 0.96 (0.15–1,1) 0.97 (0.5–1,1)
EQ-5D Worst day (min-max,median) 0.29 (−0.073–1,0.24) 0.34 (−0.073–1,0.24)
VAS Background (min-max,median) 90 (20–100,95) 89 (55–100, 90)
VAS Worst day (min-max,median) 30 (0–100,25) 30 (5–80,30)
Overall QALY loss (min-max,median) 0.008 (0–0.027,0.006) 0.0075 (0–0.044,0.006)
Overall QALD loss (min-max,median) 2.92 (0–9.84, 2.18) 2.74 (0–16.2, 2.12)